Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

NCT06864403 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pouchitis
Pouches, Ileoanal
Pouch, Ileal

Interventions

DRUG: Mirikizumab - Intravenous (IV)
DRUG: Mirikizumab - Subcutaneous (SC)

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]